IEG Policy is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBD offers opportunity for reform in FDA food and dietary supplements oversight

Ex-FDA official suggests compromise to improve public safety and provide legal path for CBD products

This article is powered by Food Chemical News

Pressure from food and dietary supplement manufacturers for a federal pathway that allows them to sell CBD products is providing Congress with a unique opportunity to close "long-standing gaps" in FDA's oversight of food additives and supplement ingredients, according to a former top agency official.

Advertisement

Related Content

Topics

What to read next

UsernamePublicRestriction

Register

PL220635

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel